FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

5070011000036107: Madopar 62.5 (benserazide 12.5 mg + levodopa 50 mg) capsule (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2452751000168112 Madopar 62.5 (benserazide 12.5 mg + levodopa 50 mg) capsule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2452761000168114 Madopar 62.5 capsule en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Madopar 62.5 capsule has manufactured dose form capsule true Inferred relationship Some
Madopar 62.5 capsule has Australian BoSS benserazide true Inferred relationship Some 1298771630
Madopar 62.5 capsule has Australian BoSS levodopa true Inferred relationship Some 1419953596
Madopar 62.5 capsule has unit of use capsule true Inferred relationship Some 1419953597
Madopar 62.5 capsule has intended active ingredient levodopa true Inferred relationship Some 1419953596
Madopar 62.5 capsule Is a trade product unit of use true Inferred relationship Some
Madopar 62.5 capsule Is a Madopar 62.5 true Inferred relationship Some
Madopar 62.5 capsule Is a levodopa 50 mg + benserazide 12.5 mg capsule true Inferred relationship Some
Madopar 62.5 capsule has manufactured dose form hard capsule false Inferred relationship Some
Madopar 62.5 capsule has intended active ingredient benserazide true Inferred relationship Some 1298771630
Inbound Relationships Type Active Source Characteristic Refinability Group
Madopar 62.5 capsule, 100 has TPUU True Madopar 62.5 capsule Inferred relationship Some 1
Madopar 62.5 capsule, 100, bottle has TPUU True Madopar 62.5 capsule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start